194 related articles for article (PubMed ID: 16616803)
1. Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.
Kimman TG; Boot HJ; Berbers GA; Vermeer-de Bondt PE; Ardine de Wit G; de Melker HE
Vaccine; 2006 May; 24(22):4769-78. PubMed ID: 16616803
[TBL] [Abstract][Full Text] [Related]
2. Decision support in vaccination policies.
Piso B; Wild C
Vaccine; 2009 Oct; 27(43):5923-8. PubMed ID: 19698809
[TBL] [Abstract][Full Text] [Related]
3. Criteria for inclusion of vaccinations in public programmes.
Houweling H; Verweij M; Ruitenberg EJ;
Vaccine; 2010 Apr; 28(17):2924-31. PubMed ID: 20189486
[TBL] [Abstract][Full Text] [Related]
4. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
Hubben GA; Bos JM; Glynn DM; van der Ende A; van Alphen L; Postma MJ
Vaccine; 2007 May; 25(18):3669-78. PubMed ID: 17360082
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
[TBL] [Abstract][Full Text] [Related]
7. [Basis for vaccine recommendations].
Lévy-Bruhl D
Med Sci (Paris); 2007 Apr; 23(4):404-8. PubMed ID: 17433231
[TBL] [Abstract][Full Text] [Related]
8. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
Patel MM; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Incorporating vaccine-preventable disease surveillance into the National Health Information Network: leveraging children's hospitals.
Fine AM; Goldmann DA; Forbes PW; Harris SK; Mandl KD
Pediatrics; 2006 Oct; 118(4):1431-8. PubMed ID: 17015533
[TBL] [Abstract][Full Text] [Related]
11. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective.
Ho AM; Nelson EA; Walker DG
Arch Dis Child; 2008 Jan; 93(1):52-8. PubMed ID: 17855438
[TBL] [Abstract][Full Text] [Related]
12. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making.
Al Awaidy S
Vaccine; 2010 Apr; 28 Suppl 1():A39-41. PubMed ID: 20412995
[TBL] [Abstract][Full Text] [Related]
13. Health system barriers to strengthening vaccine-preventable disease surveillance and response in the context of decentralization: evidence from Georgia.
Hotchkiss DR; Eisele TP; Djibuti M; Silvestre EA; Rukhadze N
BMC Public Health; 2006 Jul; 6():175. PubMed ID: 16822316
[TBL] [Abstract][Full Text] [Related]
14. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
Broughton EI
J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
[TBL] [Abstract][Full Text] [Related]
16. Management systems response to improving immunization coverage in developing countries: a case study from Cambodia.
Soeung S; Grundy J; Biggs B; Boreland M; Cane J; Samnang C; Maynard J
Rural Remote Health; 2004; 4(2):263. PubMed ID: 15884991
[TBL] [Abstract][Full Text] [Related]
17. An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases.
Rimple D; Weiss SJ; Brett M; Ernst AA
Acad Emerg Med; 2006 Sep; 13(9):922-30. PubMed ID: 16902048
[TBL] [Abstract][Full Text] [Related]
18. Developments in immunization planning in Cambodia--rethinking the culture and organization of national program planning.
Soeung S; Grundy J; Kamara L; McArthur A; Samnang C
Rural Remote Health; 2007; 7(2):630. PubMed ID: 17508838
[TBL] [Abstract][Full Text] [Related]
19. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
20. Vaccines as tools for advancing more than public health: perspectives of a former director of the National Vaccine Program office.
Breiman RF
Clin Infect Dis; 2001 Jan; 32(2):283-8. PubMed ID: 11170919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
